Log in to save to my catalogue

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the T...

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the T...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10627813

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial

About this item

Full title

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial

Publisher

England: Oxford University Press

Journal title

European heart journal. Cardiovascular pharmacotherapy, 2023-11, Vol.9 (7), p.608-616

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Aims
Clinical guidelines recommend de-escalation antiplatelet strategies to reduce bleeding risk in acute coronary syndrome (ACS) patients, albeit with a weak recommendation. This substudy of the TROPICAL-ACS trial aimed to determine the impact of body mass on the efficacy of a platelet function testing-guided de-escalation regimen i...

Alternative Titles

Full title

Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10627813

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10627813

Other Identifiers

ISSN

2055-6837

E-ISSN

2055-6845

DOI

10.1093/ehjcvp/pvad027

How to access this item